Knowledge4 Feb 2020 08:16
There has without doubt been an increase in the understanding of how cancer ‘works’ over the past few years ..
However , in actual treatments the improvement has been incremental along side increased risk of harmful side effects ..
Combinations have been somewhat ad hoc pairing products that work in similar ways I.e. inhibitor/inhibitor for example ..
While it is now considered that vaccines will be a better partner for inhibitors most vaccines to date don’t produce t-cells with high enough avidity to produce a step change in success ....
Hopefully with scancell now making Avidity a key word in all its technology platforms, it will become clear soon if Lindys’ Teams ideas become validated .. (more than already!) ..
Take care all .. just a few thoughts ..